| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.6 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |